CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 223 entries

View as:

Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01563536 Org: User:

Start: 02/29/12 End: 06/30/13 Due: 06/30/14

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01479127 Org: User:

Start: 10/31/11 End: 07/31/12 Due: 07/31/13

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal

NCT ID: NCT00686933 Org: User:

Start: 05/31/08 End: 10/31/08 Due: 10/31/09

A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT00679731 Org: User:

Start: 04/30/08 End: 11/30/09 Due: 11/30/10

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01077700 Org: User:

Start: 03/31/10 End: 07/31/11 Due: 07/31/12

EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries

Phase: N/A Priority: Normal

NCT ID: NCT01078402 Org: User:

Start: 04/30/09 End: 11/30/11 Due: 11/30/12

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT01387815 Org: User:

Start: 08/16/11 End: 06/29/18 Due: 06/29/19

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal

NCT ID: NCT01686555 Org: User:

Start: 11/30/12 End: 06/30/15 Due: 06/30/16

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00297089 Org: User:

Start: 11/30/06 End: 01/31/09 Due: 01/31/10

A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma

Phase: N/A Priority: Normal

NCT ID: NCT00742560 Org: User:

Start: 08/31/08 End: 10/31/16 Due: 10/31/17

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

Phase: N/A Priority: Normal

NCT ID: NCT00524537 Org: User:

Start: 09/30/07 End: 12/31/15 Due: 12/31/16

Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany

Phase: N/A Priority: Normal

NCT ID: NCT01155193 Org: User:

Start: 09/01/02 End: 07/31/16 Due: 07/31/17

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Phase: N/A Priority: Normal

NCT ID: NCT01156532 Org: User:

Start: 11/30/10 End: 08/31/13 Due: 08/31/14

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

Phase: N/A Priority: Normal

NCT ID: NCT01078558 Org: User:

Start: 05/13/04 End: 01/11/18 Due: 01/11/19

A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01560104 Org: User:

Start: 02/29/12 End: 09/30/14 Due: 09/30/15

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal

NCT ID: NCT01685203 Org: User:

Start: 08/31/12 End: 02/28/15 Due: 02/28/16

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal

NCT ID: NCT01020487 Org: User:

Start: 02/28/10 End: 12/31/14 Due: 12/31/15

Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

Phase: N/A Priority: Normal

NCT ID: NCT01079182 Org: User:

Start: 01/31/06 End: 05/31/14 Due: 05/31/15

A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

Phase: N/A Priority: Normal

NCT ID: NCT01464021 Org: User:

Start: 12/31/11 End: 12/31/12 Due: 12/31/13

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

Phase: N/A Priority: Normal

NCT ID: NCT00616772 Org: User:

Start: 02/29/08 End: 09/30/12 Due: 09/30/13

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal

NCT ID: NCT00640185 Org: User:

Start: 03/31/08 End: 08/31/08 Due: 08/31/09

Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

Phase: N/A Priority: Normal

NCT ID: NCT01124838 Org: User:

Start: 08/31/10 End: 05/31/15 Due: 05/31/16

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01527916 Org: User:

Start: 02/29/12 End: 11/30/13 Due: 11/30/14

Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01657799 Org: User:

Start: 10/19/12 End: 01/22/15 Due: 01/22/16

Phase 2 Chronic Low Back Pain Study

Phase: N/A Priority: Normal

NCT ID: NCT01364922 Org: User:

Start: 06/30/11 End: 10/31/11 Due: 10/31/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects	NCT01563536	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-02-29	2013-06-30	2014-06-30	-	-	2025-07-14
Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease	NCT01479127	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-10-31	2012-07-31	2013-07-31	-	-	2025-07-14
Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)	NCT00686933	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-05-31	2008-10-31	2009-10-31	-	-	2025-07-14
A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis	NCT00679731	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-04-30	2009-11-30	2010-11-30	-	-	2025-07-14
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia	NCT01077700	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-03-31	2011-07-31	2012-07-31	-	-	2025-07-14
EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries	NCT01078402	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-04-30	2011-11-30	2012-11-30	-	-	2025-07-14
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis	NCT01387815	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-08-16	2018-06-29	2019-06-29	-	-	2025-07-14
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)	NCT01686555	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-11-30	2015-06-30	2016-06-30	-	-	2025-07-14
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer	NCT00297089	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2006-11-30	2009-01-31	2010-01-31	-	-	2025-07-14
A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma	NCT00742560	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-08-31	2016-10-31	2017-10-31	-	-	2025-07-14
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)	NCT00524537	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-09-30	2015-12-31	2016-12-31	-	-	2025-07-14
Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany	NCT01155193	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2002-09-01	2016-07-31	2017-07-31	-	-	2025-07-14
Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy	NCT01156532	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-11-30	2013-08-31	2014-08-31	-	-	2025-07-14
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )	NCT01078558	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2004-05-13	2018-01-11	2019-01-11	-	-	2025-07-14
A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	NCT01560104	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-02-29	2014-09-30	2015-09-30	-	-	2025-07-14
A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection	NCT01685203	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-08-31	2015-02-28	2016-02-28	-	-	2025-07-14
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)	NCT01020487	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-02-28	2014-12-31	2015-12-31	-	-	2025-07-14
Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)	NCT01079182	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2006-01-31	2014-05-31	2015-05-31	-	-	2025-07-14
A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China	NCT01464021	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-12-31	2012-12-31	2013-12-31	-	-	2025-07-14
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood	NCT00616772	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-02-29	2012-09-30	2013-09-30	-	-	2025-07-14
Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)	NCT00640185	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-03-31	2008-08-31	2009-08-31	-	-	2025-07-14
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis	NCT01124838	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-08-31	2015-05-31	2016-05-31	-	-	2025-07-14
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease	NCT01527916	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-02-29	2013-11-30	2014-11-30	-	-	2025-07-14
Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer	NCT01657799	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-10-19	2015-01-22	2016-01-22	-	-	2025-07-14
Phase 2 Chronic Low Back Pain Study	NCT01364922	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-06-30	2011-10-31	2012-10-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance